Partner Channels: Auctions | Auto | Bill Pay | IT Education | Jobs | Lifestyle | Technology | Travel
May 1, 2001
|
|
|
|
|
|
||
|
Channels: Astrology | Broadband | Contests | E-cards | Money | Movies | Romance | Search | Weather | Wedding | Women Partner Channels: Auctions | Auto | Bill Pay | IT Education | Jobs | Lifestyle | Technology | Travel |
||
|
|
||
|
Home >
Money > Business Headlines > Report May 1, 2001 |
Feedback
|
|
|
Govt rejects Pfizer's bulk drug proposalPartha Ghosh The government has rejected US drug major Pfizer's plan to manufacture bulk drugs in India by licensing or tolling the productions to third parties or an existing Indian joint venture, Pfizer India Ltd. After nearly eight months of dilly-dallying on the issue, the department of chemicals and petrochemicals in the ministry of chemicals and fertiliser, has ruled that the company's proposal cannot be supported under the existing drug policy. According to sources, the rejection indicates the government's decision not to permit bulk drug manufacturing through licensing or tolling arrangements with third party domestic drug makers in the future. Analysts had earlier opined that a favourable decision would have prompted several foreign majors to increase investments in India, outsource bulk drugs from third parties and explore the possibility of exports. Indian manufacturers with idle capacities would also have largely benefited. Pfizer India Ltd manufactures drugs and formulations such as Sulbactum, Ampicilin, Flucanazole, Tinidazole and Pyrantel Promaote. Powered by YOU MAY ALSO WANT TO READ:
|
||||
